By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Phone: n/a Fax: n/a


AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.

Key Statistics

Ownership: Public

Web Site: AbbVie
Symbol: ABBV


Company News
If Allergan Inc. (AGN) Survives Valeant (VRX), AbbVie (ABBV)/Shire or Actavis (ACT)/Forest May Be Suitors 9/30/2014 3:50:01 PM
AbbVie (ABBV) Presents Results From Multiple Studies Of Investigational Compound Veliparib In Patients With Non-Small Cell Lung Cancer At The European Society For Medical Oncology Annual Congress 9/29/2014 8:40:55 AM
AbbVie (ABBV)'s HUMIRA® (adalimumab) Receives U.S. FDA Approval For The Treatment Of Pediatric Patients With Moderately To Severely Active Crohn's Disease 9/25/2014 8:12:42 AM
AbbVie (ABBV) Declares Quarterly Dividend 9/22/2014 7:55:02 AM
AbbVie (ABBV) To Present Clinical Study Data On Potential New Oncology Medicines At The 2014 European Society Of Medical Oncology Annual Meeting 9/22/2014 7:30:31 AM
AbbVie (ABBV) Sued By Louisiana Pension Fund Over $54.5 Billion Shire Pharmaceuticals (SHPG) Deal 9/18/2014 6:38:01 AM
Detailed Results From Biogen Idec, Inc. (Massachusetts) (BIIB) And AbbVie (ABBV)’s Pivotal Phase 3 Decide Study Further Define The Efficacy And Safety Profile Of ZINBRYTA™ (Daclizumab High-Yield Process) 9/12/2014 10:51:06 AM
AbbVie (ABBV)-Backed Virobay Inc. Lines Up $50 Million IPO 9/11/2014 6:42:50 AM
AbbVie (ABBV)'s Phase 3 Trial Of Humira Meets Primary Endpoint 9/11/2014 6:24:20 AM
AbbVie (ABBV), Teva Pharmaceutical Industries Limited (TEVA) Illegally Blocked Generic Version Of AndroGel: Federal Trade Commission 9/9/2014 5:50:47 AM